Cornea Updates

Mitomycin C increases corneal haze after corneal crosslinking

Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.

What is happening with LipiFlow reimbursement?

Cynthia Matossian, MD, FACS, ABES, takes a look at the recent, sudden change in low-payment reimbursement by Medicare Administrative Contractors for LipFlow and MGD procedure codes.

Assessing the severity of Fuchs’ endothelial corneal dystrophy by using Scheimpflug tomography

Investigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.

Deep learning for detection of keratoconus and prediction of CXL efficacy

September 24, 2021

A study sought to implement and test a trained deep learning algorithm using pre-operative corneal topography scans in order to classify between keratoconus and normal corneas, stage the disease, and predict whether a patient will be likely to benefit from CXL treatment.

Considering keratoconus-like changes after DMEK in Fuchs' dystrophy

September 20, 2021

A retrospective review was performed to describe changes in corneal thickness and to identify the incidence of posterior corneal changes characteristic of keratoconus, following DMEK surgery. Here’s what investigators found.